Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | KR3XD | — |
65 year-old female patient received Engerix-B pediatric dose; 65 year-old female patient received Engerix-B pediatric dose by mistake; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 65-year-old female patient who received HBV (Engerix B pediatric) (batch number KR3XD, expiry date 17-FEB-2025) for prophylaxis. On 13-JAN-2025, the patient received the 1st dose of Engerix B pediatric. On 13-JAN-2025, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: 65 year-old female patient received Engerix-B pediatric dose) and accidental underdose (Verbatim: 65 year-old female patient received Engerix-B pediatric dose by mistake). The outcome of the adult use of a child product and accidental underdose were unknown. Additional Information: GSK Receipt Date: 13-JAN-2025 The patient received Engerix-B pediatric dose by mistake as a possible first dose in the series, which led to adult use of a child product and accidental underdose.